NCT03733041View on ClinicalTrials.gov

Neuromodulation for Exercise Adherence

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 31, 2025

Study Completion Date

May 31, 2025

Conditions
Executive DysfunctionPoor Exercise Adherence
Interventions
DEVICE

rTMS

This group will receive rTMS treatment

DEVICE

Sham

This group will receive sham treatment

OTHER

No intervention

This group will receive no intervention

Trial Locations (1)

72205

Central Arkansas Veterans Healthcare System , Little Rock, AR, Little Rock

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03733041 - Neuromodulation for Exercise Adherence | Biotech Hunter | Biotech Hunter